National Science Library of Georgia

Understanding physician-pharmaceutical industry interactions / (Record no. 520686)

MARC details
000 -LEADER
fixed length control field 03491nam a22003858i 4500
001 - CONTROL NUMBER
control field CR9780511665677
003 - CONTROL NUMBER IDENTIFIER
control field UkCbUP
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20200124160305.0
006 - FIXED-LENGTH DATA ELEMENTS--ADDITIONAL MATERIAL CHARACTERISTICS--GENERAL INFORMATION
fixed length control field m|||||o||d||||||||
007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION
fixed length control field cr||||||||||||
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 141103s2007||||enk o ||1 0|eng|d
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 9780511665677 (ebook)
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
Cancelled/invalid ISBN 9780521868648 (hardback)
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
Cancelled/invalid ISBN 9780521688666 (paperback)
040 ## - CATALOGING SOURCE
Original cataloging agency UkCbUP
Language of cataloging eng
Description conventions rda
Transcribing agency UkCbUP
050 00 - LIBRARY OF CONGRESS CALL NUMBER
Classification number R727.5
Item number .J35 2007
082 00 - DEWEY DECIMAL CLASSIFICATION NUMBER
Classification number 174.2/951
Edition number 22
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Jain, Shaili,
Dates associated with a name 1974-
Relator term author.
245 10 - TITLE STATEMENT
Title Understanding physician-pharmaceutical industry interactions /
Statement of responsibility, etc Shaili Jain.
264 #1 - Production, Publication, Distribution, Manufacture, and Copyright Notice (R)
Place of production, publication, distribution, manufacture (R) Cambridge :
Name of producer, publisher, distributor, manufacturer (R) Cambridge University Press,
Date of production, publication, distribution, manufacture, or copyright notice 2007.
300 ## - PHYSICAL DESCRIPTION
Extent 1 online resource (xviii, 141 pages) :
Other physical details digital, PDF file(s).
336 ## - Content Type (R)
Content type term (R) text
Content type code (R) txt
Source (NR) rdacontent
337 ## - Media Type (R)
Media type term (R) computer
Media type code (R) c
Source (NR) rdamedia
338 ## - Carrier Type (R)
Carrier type term (R) online resource
Carrier type code (R) cr
Source (NR) rdacarrier
500 ## - GENERAL NOTE
General note Title from publisher's bibliographic system (viewed on 05 Oct 2015).
505 0# - FORMATTED CONTENTS NOTE
Formatted contents note Gifts from the pharmaceutical industry to physicians: do they influence your prescribing? -- Ethical considerations of receiving gifts from the pharmaceutical industry -- One on one: an analysis of the physician-pharmaceutical company representative (PCR) detailing interaction -- Medical academia and the pharmaceutical industry -- Teaching physicians in training about pharmaceutical industry promotion -- Continuing medical education: how to separate continuing medical education from pharmaceutical industry promotion -- Professional policies on physician-pharmaceutical industry interactions (PPII) -- Preserving professionalism: patients' perceptions of physicians' acceptance of gifts from the pharmaceutical industry --
505 0# - FORMATTED CONTENTS NOTE
Formatted contents note To sample or not to sample? the use of pharmaceutical industry supplied medications in medical practice -- Physician-pharmaceutical industry interactions (PPII), the law and the media -- Direct-to-consumer advertising (DTCA) -- Pharmaceutical industry interactions with health care professionals: a global perspective -- Internet resources for teaching about PPII and independent sources of information about prescription medicines.
520 ## - SUMMARY, ETC.
Summary, etc Physician-pharmaceutical industry interactions continue to generate heated debate in academic and public domains, both in the United States and abroad. Despite this, recent research suggests that physicians and physicians-in-training remain uninformed of the core issues and are ill-prepared to understand pharmaceutical industry promotion. Furthermore, few medical curricula address this issue, despite warnings of the imperative need to address this gap in the education of tomorrow's physicians. There is a vast medical literature on this topic, but no single, concise resource. This book aims to fill that gap by providing a resource that explains the essential elements of this subject. The text makes the reader more aware of the key ethical issues and allows the reader to be a more savvy interpreter of industry promotion, have a heightened awareness of the public and medical legal consequences of some physician-pharmaceutical industry interactions, and be better equipped to handle real-life encounters with industry.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Physicians
General subdivision Professional ethics.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Pharmaceutical industry
General subdivision Moral and ethical aspects.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Drugs
General subdivision Marketing.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Advertising
General subdivision Drugs.
776 08 - ADDITIONAL PHYSICAL FORM ENTRY
Display text Print version:
International Standard Book Number 9780521868648
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.1017/CBO9780511665677">https://doi.org/10.1017/CBO9780511665677</a>

No items available.

Copyright © 2023 Sciencelib.ge All rights reserved.